Amanta invests Rs 45 crore for production expansion

Formerly known as Marck Bioscience, now Amanta Healthcare, today announced that it is investing Rs 45 crore as part of expanding its production facility


(Photo Courtesy:

Amanta manufactures and markets sterile liquid parenterals using aseptic blow-fill-seal technology.

The company is also planning to recruit 200-225 professionals, it said in a statement on Tuesday.

Speaking on the occasion, Mr Bhavesh Patel, MD, Amanta Healthcare said, "...In the near future, we will be strengthening our product basket for the international market, especially for Asian countries. We are naturally inclined towards adapting new concepts and technology and our future offering would be primarily a result of such initiatives".

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email